Safety and Pharmacokinetics of PSD502 in Healthy Chinese Male and Female Volunteers: Two Randomized, Double-Blind, Placebo-Controlled, Phase I Trials.
Fangfang WangZhiping LiuXiaoye NiuLin ZhaoJixiang ZhuLinjing QiLu LiuZiyang LiuYunan SunLei DiaoJun LuYongchun ZhouXiaoye WangHaiyan LiPublished in: Clinical drug investigation (2023)
PSD502 was well tolerated and showed low plasma concentrations in healthy Chinese male and female individuals.